Published in Vaccine on March 01, 1997
The immunogenicity of a single dose of hepatitis A virus vaccines (Havrix® and Epaxal®) in Korean young adults. Yonsei Med J (2014) 0.85
Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children. Vaccine (2013) 0.84
Seropositivity among Korean Young Adults Approximately 2 Years after a Single-Dose Vaccination against Hepatitis A Virus. PLoS One (2015) 0.77
Aventis Pasteur vaccines containing inactivated hepatitis A virus: a compilation of immunogenicity data. Eur J Clin Microbiol Infect Dis (2004) 0.77
Pertussis in adults: frequency of transmission after household exposure. Lancet (1995) 2.16
Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ (2008) 2.16
Heteroresistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis (2001) 2.10
Direct amplification and species determination of microsporidian DNA from stool specimens. Trop Med Int Health (1996) 1.85
Zoonotic potential of Enterocytozoon bieneusi. J Clin Microbiol (2001) 1.82
Close genotypic relationship between Enterocytozoon bieneusi from humans and pigs and first detection in cattle. J Parasitol (2000) 1.80
Safety and reactogenicity of a low dose diphtheria tetanus acellular pertussis vaccine (Boostrix) in pre-school Indian children. Indian Pediatr (2007) 1.74
Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR). J Virol Methods (2000) 1.71
Evidence for the existence of genetically distinct strains of Enterocytozoon bieneusi. Parasitol Res (1997) 1.65
Serological pattern "anti-HBc alone": report on a workshop. J Med Virol (2000) 1.65
Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA (1996) 1.60
Sensitivity and specificity of dipstick tests for rapid diagnosis of malaria in nonimmune travelers. J Clin Microbiol (1999) 1.59
Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J Virol (1995) 1.57
Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg (2001) 1.50
Hepatitis C - contamination of toothbrushes: myth or reality? J Viral Hepat (2006) 1.48
Hepatitis B vaccination: how long does protection last? Lancet (1984) 1.43
[Epidemiology of echinococcosis in Bavaria]. Dtsch Med Wochenschr (1995) 1.42
Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine (2009) 1.39
Diagnostic significance of blood eosinophilia in returning travelers. Clin Infect Dis (2001) 1.36
Cutaneous larva migrans in travelers: synopsis of histories, symptoms, and treatment of 98 patients. Clin Infect Dis (1994) 1.35
Clinical evaluation of a recombinant hepatitis B vaccine. Lancet (1984) 1.33
Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway. Br J Haematol (1994) 1.30
Strain differentiation in microsporidia. Tokai J Exp Clin Med (1998) 1.29
Usefulness of Mycobacterium tuberculosis genomic mutations in the genes katG and inhA for the prediction of isoniazid resistance. Int J Tuberc Lung Dis (1997) 1.26
Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B/ Haemophilus influenzae type b vaccine in Indian infants. Indian Pediatr (2007) 1.25
[Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline]. Z Gastroenterol (2011) 1.24
Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine (2009) 1.22
Human dirofilariasis. Int J Dermatol (1996) 1.22
Comparison of nine commercially available assays for quantification of antibody response to hepatitis B virus surface antigen. J Clin Microbiol (2008) 1.20
Disequilibria in the distribution of rpoB alleles in rifampicin-resistant M. tuberculosis isolates from Germany and Sierra Leone. Microb Drug Resist (1997) 1.20
Age related seroprevalence of antibodies to varicella in India. Indian Pediatr (2000) 1.18
Epidemiology of alveolar echinococcosis in southern Germany (Bavaria). Infection (1995) 1.18
Cutaneous myiasis: review of 13 cases in travelers returning from tropical countries. Int J Dermatol (1995) 1.17
Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant (2004) 1.17
Blinded, externally controlled multicenter evaluation of light microscopy and PCR for detection of microsporidia in stool specimens. The Diagnostic Multicenter Study Group on Microsporidia. J Clin Microbiol (1998) 1.14
Cases of chikungunya imported into Europe. Euro Surveill (2006) 1.14
Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor. J Viral Hepat (2007) 1.10
Detection of embB codon 306 mutations in ethambutol resistant Mycobacterium tuberculosis directly from sputum samples: a low-cost, rapid approach. Mol Cell Probes (2001) 1.10
Sensitivity and specificity of a rapid immunochromatographic test for diagnosis of visceral leishmaniasis. Eur J Clin Microbiol Infect Dis (1999) 1.09
Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis. Mol Cell Probes (1997) 1.08
The economic burden of hepatitis B in Germany. Eur J Epidemiol (2000) 1.05
Controlled study on enteropathogens in travellers returning from the tropics with and without diarrhoea. Clin Microbiol Infect (2010) 1.05
Rapid identification of mycobacterial species by PCR amplification of hypervariable 16S rRNA gene promoter region. J Clin Microbiol (1996) 1.05
Expression of the Epstein-Barr virus 138-kDa early protein in Escherichia coli for the use as antigen in diagnostic tests. Gene (1986) 1.05
Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance. Vaccine (1997) 1.05
Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell lines. J Virol (1994) 1.05
Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia. Proc Natl Acad Sci U S A (1991) 1.03
Detection of hepatitis B virus in serum using amplification of viral DNA by means of the polymerase chain reaction. J Med Virol (1989) 1.03
Population structure of recrudescent Plasmodium falciparum isolates from western Uganda. Trop Med Int Health (1999) 1.02
Quinine resistant falciparum malaria acquired in east Africa. Trop Med Parasitol (1995) 1.02
Results of immunisation with a recombinant yeast-derived hepatitis B vaccine. J Infect (1986) 1.02
Adverse reactions to Japanese encephalitis vaccine in travellers. J Infect (1996) 1.01
Prevalence of infection with dengue virus among international travelers. Arch Intern Med (1997) 1.00
Clinical features and epidemiology of tick typhus in travelers. J Travel Med (2001) 1.00
Assessing the incidence of infection with Plasmodium falciparum among international travelers. Am J Trop Med Hyg (1998) 1.00
Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010. Euro Surveill (2010) 0.99
Decline of anti-HBs after hepatitis B vaccination and timing of revaccination. Lancet (1990) 0.99
Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes. J Virol (1998) 0.98
Correlation of in vivo-resistance to chloroquine and allelic polymorphisms in Plasmodium falciparum isolates from Uganda. Trop Med Int Health (2000) 0.98
Human infection with Gongylonema pulchrum: a case report. Trop Med Parasitol (1994) 0.96
Prevalence of antibodies against hepatitis C virus in the adult German population. Eur J Gastroenterol Hepatol (1999) 0.93
The new DTPw-HBV-Hib combination vaccine can be used at the who schedule with a monovalent dose of hepatitis B vaccine at birth. Southeast Asian J Trop Med Public Health (1998) 0.93
Symptoms and complications of pertussis in adults. Infection (1996) 0.93
[Severe oral mucositis in a patient with HIV infection]. Dtsch Med Wochenschr (2013) 0.93
Comparison of polymerase chain reaction with light microscopy for detection of microsporidia in clinical specimens. Eur J Clin Microbiol Infect Dis (1997) 0.92
Comparative study on infection-induced thrombocytopenia among returned travellers. Infection (2012) 0.92
Culture-independent prediction of isoniazid resistance in Mycobacterium tuberculosis by katG gene analysis directly from sputum samples. Mol Diagn (1999) 0.92
Sensitive ELISA dipstick test for the detection of chloroquine in urine under field conditions. Trop Med Int Health (1998) 0.92
Immunogenicity of a recombinant hepatitis B vaccine in adults. Arch Intern Med (1996) 0.91
Diphtheria booster vaccination: one or two injections? Vaccine (1999) 0.91
Sporadic cases of acute autochthonous hepatitis E virus infection in Southwest Germany. J Clin Virol (2009) 0.90
Skin disorders among travellers returning from tropical and non-tropical countries consulting a travel medicine clinic. Trop Med Int Health (2011) 0.90
Autochthonous hepatitis E virus infection in Germany with sequence similarities to other European isolates. Infection (2006) 0.90
Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination. Eur J Clin Microbiol Infect Dis (1992) 0.90
A rotavirus vaccine for infants: the Asian experience. Ann Acad Med Singapore (2006) 0.90
Foodborne hepatitis A outbreak associated with bakery products in northern Germany, 2012. Euro Surveill (2014) 0.90
A novel deletion mutant of hepatitis B virus surface antigen. J Med Virol (1999) 0.90
Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection. Z Gastroenterol (2007) 0.89
Epidemiological, clinical, and diagnostic data on intestinal infections with Entamoeba histolytica and Entamoeba dispar among returning travelers. Infection (2011) 0.89
Excision of pre-ulcerative forms of Buruli ulcer disease: a curative treatment? Infection (2008) 0.89
Risk factors of chloroquine resistance in Plasmodium falciparum malaria. Acta Trop (1996) 0.89
Detection of hepatitis B virus DNA in serum by a rapid filtration-hybridization assay. J Virol Methods (1985) 0.88
Antibody responses and skin reactivity after intradermal hepatitis B virus vaccine. Lancet (1984) 0.88
[Persistent arthralgias in Ross-River-Virus disease after travel to the South Pacific]. Dtsch Med Wochenschr (1999) 0.87
Fatal malaria in a German couple returning from Burkina Faso. Infection (2003) 0.87
Infection-induced anaemia: a cross-sectional study of 14,636 German travellers aged 20-49 years. Infection (2013) 0.87
Patterns of Plasmodium falciparum drug resistance in nonimmune travellers to Africa. Eur J Clin Microbiol Infect Dis (2001) 0.87
Immunogenicity and safety of an inactivated hepatitis A vaccine in anti-HIV positive and negative homosexual men. J Med Virol (1995) 0.87
Evaluation of an antigen-capture enzyme immunoassay for detection of Entamoeba histolytica in stool samples. Eur J Clin Microbiol Infect Dis (1996) 0.85
Substantial decline of notified hepatitis B in major parts of Europe after 1985. Scand J Infect Dis (1994) 0.85
Immune responses to late booster doses of hepatitis B vaccine. J Med Virol (1985) 0.85
Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers. Virology (1999) 0.85
Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination. Infection (2007) 0.85
Prevalence of precore mutants in anti-HBe-positive hepatitis B virus carriers in Germany. J Med Virol (1999) 0.85
Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis (1998) 0.85
The role of Blastocystis hominis as a possible intestinal pathogen in travellers. J Infect (1997) 0.84